[1] |
PAN Jian, YE Dingwei, ZHU Yao, WANG Beihe.
Correlation analysis of PSMA PET/CT-derived parameters and circulating tumor DNA features in patients with hormone-sensitive prostate cancer
[J]. China Oncology, 2024, 34(7): 680-685.
|
[2] |
JIANG Lin, LIU Qiying, JIA Liqing, ZHANG Jing, CHANG Heng, XUE Tian, REN Min, BAI Qianming, ZHU Xiaoli, ZHOU Xiaoyan.
Retrospective study on MGMT methylation status and its clinical significance in gliomas
[J]. China Oncology, 2023, 33(8): 740-750.
|
[3] |
CHEN Man, ZENG Feiyan, LI Qingqing, LI Hongdan, LIN Yansong, FENG Ping.
A meta-analysis of the efficacy of 99Tc-MDP alone and in combination with 89SrCl2 in the treatment of bone metastases
[J]. China Oncology, 2023, 33(8): 751-767.
|
[4] |
CHEN Lijun, WANG Yichen, ZHENG Qiang, WANG Yue, JIN Yan, LI Yuan.
Consistency analysis of PD-L1 immunohistochemistry antibodies in esophageal squamous cell carcinoma
[J]. China Oncology, 2023, 33(5): 469-477.
|
[5] |
SHE Youjun, GUO Zihan, ZHANG Zhongwei, DU Qiong.
Evaluation of adverse events of CDK4/6 inhibitors: a real-world study based on the FAERS database
[J]. China Oncology, 2023, 33(10): 908-919.
|
[6] |
ZHOU Changshuai, YANG Yuechao, CUI Huanhuan, CHEN Lei, CHEN Xin, HAO Bin, TONG Tong, CAO Yiqun.
Prognostic factor analysis of surgical treatment for cerebellar metastases in 36 patients
[J]. China Oncology, 2022, 32(4): 357-362.
|
[7] |
WU Mengyin, WU Chunxiao, PANG Yi, WANG Chunfang, GU Kai, GONG Yangming, BAO Pingping, SHI Liang, DOU Jianming, XIANG Yongmei, SHI Yan.
Incidence and mortality of pancreatic cancer in Shanghai 2016 and epidemic trend analysis from 2002 to 2016
[J]. China Oncology, 2022, 32(2): 97-105.
|
[8] |
LIN Xinyi, SUN Wei, HU Tu, WANG Chunmeng, YAN Wangjun, LUO Zhiguo, LIU Xin, ZHONG Jingqin, ZOU Zijian, XU Yu, CHEN Yong.
Multivariable prognostic analyses of Chinese acral and cutaneous melanoma after surgical treatment for the past five years in a single cancer center
[J]. China Oncology, 2022, 32(12): 1158-1167.
|
[9] |
MEI Xiaoran, FENG Fang, WANG Hui, WEI Zhixiao.
Analysis of therapeutic response of iodine positive metastasis lymph nodes in differentiated thyroid cancer after 131I treatment
[J]. China Oncology, 2022, 32(11): 1091-1097.
|
[10] |
ZHU Yi, XIAO Bin, LIU Jiahui, HUANG Ling, SUN Zhaohui, LI Linhai.
Expression, localization, biological role and proteomics study of circ-0003910 in HER2-positive breast cancer
[J]. China Oncology, 2022, 32(10): 979-989.
|
[11] |
WANG Zezhou , ZHANG Yang , MO Miao , YUAN Jing , ZHOU Changming , SHEN Jie , FENG Xiaoshuang , WU Haoxuan , LI Hang , YE Ting , HU Hong , CHEN Haiquan , ZHENG Ying .
Distribution of metastatic sites and survival analysis of patients with non-metastatic lung cancer at initial diagnosis based on hospital registration
[J]. China Oncology, 2021, 31(9): 775-782.
|
[12] |
GONG Chao , CHEN Kui , ZHANG Dekun , XIE Jingfeng , WU Fanghua , HUANG Yudian , XUE Yuqin , WANG Liqun .
Construction of a prediction model for metastasis in gastric cancer based on the weighted gene co-expression network analysis
[J]. China Oncology, 2021, 31(8): 746-753.
|
[13] |
JIANG Chaoyang , WANG Juan , ZHANG Ling , GAO Hui , ZHANG Tao , LI Zhihui .
Correlation analysis of neck node levels in 709 cases of nasopharyngeal carcinoma
[J]. China Oncology, 2021, 31(7): 629-634.
|
[14] |
WU Yuanyuan , WANG Jun , LIU Qinjiang , ZHANG Ming .
Analysis of prognostic factors and treatment strategies of anaplastic thyroid carcinoma
[J]. China Oncology, 2021, 31(3): 212-220.
|
[15] |
LIU Jiawei, LI Dan, ZHAI Qing.
Risk factors analysis of liver injury induced by chemotherapy in patients with breast cancer
[J]. China Oncology, 2021, 31(1): 52-62.
|